IL7R: A Protein Targeted for Drug Development (G3575)

Target Name: IL7R

NCBI ID: G3575

IL7R

IL7R: A Protein Targeted for Drug Development

IL7R (Interleukin-7 Receptor) is a protein that is expressed in various tissues throughout the body, including the immune system, skin, and nervous system. It plays a crucial role in the regulation of inflammation and immune responses. The IL7R gene has been identified as a potential drug target for the treatment of various diseases, including cancer, autoimmune disorders, and inflammatory diseases.

The IL7R protein is composed of two subunits, a type of protein called a cytoplasmic protein (CP) and a type of protein called a transmembrane protein (TMP). The CP is responsible for the interaction with the TMP, which is responsible for the actual interaction with the cell surface. The CP and TMP form a complex that is involved in the regulation of various cellular processes, including cell signaling, inflammation, and immune responses.

One of the key functions of the IL7R protein is its role in the regulation of T cell responses. T cells are a type of immune cell that play a crucial role in the regulation of the immune system. They are responsible for recognizing and responding to foreign antigens, including viruses and bacteria. The IL7R protein is involved in the regulation of T cell responses by interacting with the TMP, which in turn affects the activity of the downstream signaling pathways that regulate T cell responses.

The IL7R protein is also involved in the regulation of inflammation. Inflammation is a critical response of the immune system to harmful stimuli, including bacteria, viruses, and other foreign substances. The IL7R protein is involved in the regulation of inflammation by interacting with the TMP, which in turn affects the production and function of pro-inflammatory cytokines. These cytokines play a crucial role in the regulation of inflammation and tissue damage.

The IL7R protein is also involved in the regulation of pain perception. Pain perception is a critical aspect of the immune system's response to noxious stimuli, including pain caused by injury or disease. The IL7R protein is involved in the regulation of pain perception by interacting with the TMP, which in turn affects the production and function of pain-related cytokines. These cytokines play a crucial role in the regulation of pain perception and the modulation of pain sensitivity.

In addition to its role in the regulation of inflammation and pain perception, the IL7R protein is also involved in the regulation of stem cell biology. Stem cells are a type of cell that have the ability to self-renew and differentiate into various cell types in the body. The IL7R protein is involved in the regulation of stem cell biology by interacting with the TMP, which in turn affects the production and function of stem cells.

The IL7R protein is also involved in the regulation of tissue homeostasis. Tissue homeostasis refers to the ability of tissues to maintain their structure and function in the face of various external stimuli, including mechanical, thermal, and chemical stimuli. The IL7R protein is involved in the regulation of tissue homeostasis by interacting with the TMP, which in turn affects the production and function of tissues.

In conclusion, the IL7R protein is a critical regulator of various cellular processes in the body. Its involvement in the regulation of inflammation, pain perception, stem cell biology, and tissue homeostasis makes it an attractive drug target for the treatment of various diseases. The development of compounds that can specifically target the IL7R protein may lead to new treatments for a range of diseases, including cancer, autoimmune disorders, and inflammatory diseases.

Protein Name: Interleukin 7 Receptor

Functions: Receptor for interleukin-7. Also acts as a receptor for thymic stromal lymphopoietin (TSLP)

The "IL7R Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IL7R comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets